ArticleInternational journal of women's health2026
Epidural Analgesia Duration and Postpartum Blood Pressure Trajectory in Hypertensive Pregnancies: A Time-to-Event Analysis.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Postpartum hypertension (PPHTN) drives severe maternal morbidity in women with hypertensive disorders of pregnancy (HDP). The uncharacterized effect of labor epidural analgesia (LEA) on postpartum blood pressure trajectories may explain its protective association with severe maternal morbidity. We aim to investigate whether LEA exposure is associated with a delayed onset of PPHTN during hospitalization in women with HDP. Methods: We conducted a retrospective cohort study of women with HDP from 2018 to 2023. Participants were categorized based on LEA duration, with non-recipients assigned a duration of zero. An optimal LEA duration cut-off was identified using the maximally selected log-rank statistic to facilitate group comparison. The primary outcome was in-hospital PPHTN, defined as ≥2 postpartum blood pressure measurement meeting standard hypertensive criteria. Time-to-event analyses were performed using Kaplan-Meier estimates and the Log rank test. Multivariable Cox regression with DAG-guided covariate selection was used to adjust for potential confounders. Secondary outcomes included postpartum antihypertensive treatment patterns, specifically combination therapy use and daily labetalol dose. Three prespecified sensitivity analyses assessed the robustness of results. Results: Of 1,069 women included in the final analysis, 823 (77.0%) received LEA. Longer LEA duration was significantly associated with a reduced hazard of PPHTN (HR = 0.96 per hour; 95% CI: 0.93-0.98; Conclusion: Longer LEA duration was associated with a reduced risk of postpartum hypertension and lower antihypertensive use in women with HDP. These observational findings indicate that prolonged analgesia may be associated with improved postpartum hemodynamic stability, suggesting consideration for its continuation in eligible patients; prospective studies are needed to confirm causality and guide clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.